Katherine A. Rauen

UC Davis Health System — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

48h-index9.2kcitations153works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Tyrosine Phosphatases(84), Melanoma and MAPK Pathways(27), Neurofibromatosis and Schwannoma Cases(21), Galectins and Cancer Biology(20), PI3K/AKT/mTOR signaling in cancer(19)

Publications153 total

Correction: Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype–phenotype correlation
UNC Libraries·2025Open Access
Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype–phenotype correlation
2025Open Access
0555 Mutational landscape of melanocytic tumors from patients with RASopathies
Journal of Investigative Dermatology·2025Open Access
Recurrent p.<scp>H119Y</scp> variant in <scp><i>MAP2K1</i></scp> expands the phenotypic spectrum of <scp><i>MAP2K1</i></scp>‐related RASopathy
American Journal of Medical Genetics Part A·2024Open Access
400 Mutational landscape of melanocytic tumors from RASopathy patients
Journal of Investigative Dermatology·2024Open Access
Dermoscopic Features of Melanocytic Nevi in Cardiofaciocutaneous and Costello Syndromes
JAMA Dermatology·2024· 1 citedOpen Access
RASopathies – what they reveal about RAS/MAPK signaling in skeletal muscle development
Disease Models & Mechanisms·2024· 11 citedOpen Access
Translating multiscale research in rare disease
Disease Models & Mechanisms·2024· 1 citedOpen Access
Cardio-Facio-Cutaneous Syndrome
2024· 3 cited
What Is a RASopathy?
2024
The <scp>8th International RASopathies Symposium</scp>: Expanding research and care practice through global collaboration and advocacy
American Journal of Medical Genetics Part A·2023· 6 citedOpen Access
44504 Melanocytic neoplasms in neurofibromatosis type 1: A systematic review
Journal of the American Academy of Dermatology·2023Open Access
41682 Increased numbers of melanocytic neoplasms in RASopathies: A systematic review and meta-analysis
Journal of the American Academy of Dermatology·2023Open Access
Melanocytic neoplasms in neurofibromatosis type 1: a systematic review
Melanoma Research·2023· 8 citedOpen Access
The association between juvenile xanthogranulomas in neurofibromatosis type 1 patients and the development of leukaemia: A systematic review
Journal of the European Academy of Dermatology and Venereology·2023· 8 citedOpen Access
ISID1186 - Melanoma in neurofibromatosis type 1: A systematic review
2023
P302: Clinical genome sequencing and targeted mouse modeling in nonverbal or minimally verbal individuals with autism spectrum disorders and neurodevelopmental delays
Genetics in Medicine Open·2023Open Access
Obstetrical and neonatal outcomes of cardio‐facio‐cutaneous syndrome: Prenatal consequences of Ras/<scp>MAPK</scp> dysregulation
American Journal of Medical Genetics Part A·2022· 5 citedOpen Access
A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder
Genetics in Medicine·2022· 4 citedOpen Access
452 Molecular and histopathologic profiling of melanocytic nevi in patients with RASopathies
Journal of Investigative Dermatology·2022
page 1 of 8Next →

Frequent Co-authors

William E. Tidyman(8), Frank McCormick(8), David A. Stevenson(7), Eric Legius(6), David Viskochil(6), Philip D. Cotter(6), Bruce D. Gelb(6), Karen W. Gripp(6), Bruce R. Korf(5), Roger J. Packer(5), Anne L. Estep(5), Ludwine Messiaen(4), Jaishri O. Blakeley(4), David H. Gutmann(4), Elizabeth K. Schorry(4), Nicole J. Ullrich(4), Alicia Gomes(4), Dusica Babovic‐Vuksanovic(3), Rosalie E. Ferner(3), Michael J. Fisher(3)